PatchTheCVECVE-2026-105612: PostgreSQL Anonymizer contains a vulnerability that data-modifying CTEs to bypass the read-only restriction of
CVE-2026-105612 is a low-severity flaw (CVSS 3.5) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
PostgreSQL Anonymizer contains a vulnerability that data-modifying CTEs to bypass the read-only restriction of masked roles. The problem is resolved in PostgreSQL Anonymizer 3.3.0 and later versions
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 3.5 (Low) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | Required |
| EPSS exploit chance | n/a |
| CISA exploited list | No |
| Weakness | CWE-862 |
| Published | 2026-10-28 |
| Last modified | 2026-10-28 |
Last updated 2026-10-28 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Advisories and coverage
Official advisories
- PostgreSQL Security: PostgreSQL Anonymizer 3.3 : Major Security Update 2026-10-28
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-105612?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-105612 being exploited?
CVE-2026-105612 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-105612 affect?
CVE-2026-105612 affects affected software. Severity is low (CVSS 3.5). PostgreSQL Anonymizer contains a vulnerability that data-modifying CTEs to bypass the read-only restriction of masked roles. The problem is resolved in PostgreSQL Anonymizer 3.3.0 and later versions
How urgent is CVE-2026-105612?
Priority 12/100. No elevated risk signals yet.